ScholarIQanswers from OpenAlex & ORCID
Myron Schwartz
ResearcherPublications, citations & collaboration network
Myron Schwartz is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Myron Schwartz have?
ScholarIQindexed works
Myron Schwartz has 532 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Myron Schwartz have?
ScholarIQcitation count
Myron Schwartz has 51,633 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Myron Schwartz?
ScholarIQh-index
Myron Schwartz has an h-index of 101 in OpenAlex.
What is the i10-index of Myron Schwartz?
ScholarIQi10-index
Myron Schwartz has an i10-index of 289 in OpenAlex.
What is the ORCID of Myron Schwartz?
ScholarIQorcid
The ORCID for Myron Schwartz is on the source record.
What is the OpenAlex record for Myron Schwartz?
ScholarIQopenalex
The OpenAlex for Myron Schwartz is on the source record.
What are the most-cited papers on Myron Schwartz?
ScholarIQmost cited works
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
Vincenzo Mazzaferro, Josep M. Llovet, Rosalba Miceli, Sherrie Bhoori, Marcello Schiavo, Luigi Mariani, Tiziana Camerini, Sasan Roayaie, Myron Schwartz, Gian Luca Grazi, René Adam, P. Neuhaus, Mauro Salizzoni, Jordi Bruix, Alejandro Forner, Luciano De Carlis, Umberto Cillo, Andrew K. Burroughs, Roberto Troisi, Massimo Rossi, Giorgio Enrico Gerunda, Jan Lerut, Jacques Belghiti, I. Boin, Jean Gugenheim, Fedja A. Rochling, Bart van Hoek, Pietro Majno
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
Joong‐Won Park, Minshan Chen, M. Colombo, Lewis R. Roberts, Myron Schwartz, Pei‐Jer Chen, Masatoshi Kudo, Philip J. Johnson, Samuel Wagner, Lucinda Orsini, Morris Sherman
Recurrence of hepatocellular carcinoma after liver transplant: Patterns and prognosis
Sasan Roayaie, Jonathan D. Schwartz, Max W. Sung, Sukru Emre, Charles M. Miller, Gabriel Gondolesi, Nancy Krieger, Myron Schwartz
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
Assaf Magen, Pauline Hamon, Nathalie Fiaschi, Brian Y. Soong, Matthew D. Park, Raphaël Mattiuz, Étienne Humblin, Leanna Troncoso, Darwin D’souza, Travis Dawson, Joel Kim, Steven Hamel, Mark Buckup, Christie Chang, Alexandra Tabachnikova, Hara Schwartz, Nausicaa Malissen, Yonit Lavin, Alessandra Soares‐Schanoski, Bruno Giotti, Samarth Hegde, Giorgio Ioannou, Edgar Gonzalez‐Kozlova, C. Hennequin, Jessica Le Bérichel, Zhen Zhao, Stephen C. Ward, Isabel Fiel, Baijun Kou, Michael Dobosz, Lianjie Li, Christina Adler, Min Ni, Yi Wei, Wei Wang, Gurinder S. Atwal, Kunal Kundu, Kamil J. Cygan, Alexander M. Tsankov, Adeeb Rahman, Colles Price, Nicolás Fernández, Jiang He, Namita T. Gupta, Seunghee Kim‐Schulze, Sacha Gnjatic, Ephraim Kenigsberg, Raquel P. Deering, Myron Schwartz, Thomas U. Marron, Gavin Thurston, Alice O. Kamphorst, Miriam Mérad
Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: a single-arm, open-label, phase 2 trial
Thomas U. Marron, Maria Isabel Fiel, Pauline Hamon, Nathalie Fiaschi, Edward Kim, Stephen C. Ward, Zhen Zhao, Joel Kim, Paul Kennedy, Ganesh Gunasekaran, Parissa Tabrizian, Deborah B. Doroshow, Meredith Legg, Ashley Hammad, Assaf Magen, Alice O. Kamphorst, Muhammed Shareef, Namita Gupta, Raquel P. Deering, Wei Wang, Fang Wang, Pradeep Thanigaimani, Jayakumar Mani, Leanna Troncoso, Alexandra Tabachnikova, Christie Chang, Güray Aktürk, Mark Buckup, Steven Hamel, Giorgio Ioannou, C. Hennequin, Hajra Jamal, Haley E. Brown, Antoinette Bonaccorso, Daniel M. Labow, Umut Sarpel, Talia D. Rosenbloom, Max W. Sung, Baijun Kou, Siyu Li, Vladimir Janković, Nicola James, Sara Hamon, Hung Kam Cheung, Jennifer S. Sims, Elizabeth Miller, Nina Bhardwaj, Gavin Thurston, Israel Lowy, Sacha Gnjatic, Bachir Taouli, Myron Schwartz, Miriam Mérad